Is Another Sharp PM Sector Down-Leg Imminent?
Source: Clive Maund for Streetwise Reports  (11/22/19)
Technical analyst Clive Maund examines the data and answers the question. More >

NexTech AR Solutions Update After Major Ramp-Up
Source: Clive Maund for Streetwise Reports  (11/22/19)
Technical analyst Clive Maund provides an update on the prospects for this technology firm. More >

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data
Source: Streetwise Reports  (11/22/19)
EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. More >

Canadian Gold Miner Achieves 'Strong Q3/19 Operationally'
Source: Streetwise Reports  (11/21/19)
The company's performance during the quarter is covered in a Haywood report. More >

Underground Sampling Extended at Past-Producing Nevada Mine
Source: Streetwise Reports  (11/21/19)
The mine developer extends its sampling program to include two historical shafts. More >

Aftermath Locks up a Boatload of Silver
Source: Bob Moriarty for Streetwise Reports  (11/21/19)
Bob Moriarty of 321gold profiles one of the few pure-play silver companies. More >

Cannabis Firm's Stock Poised for 'Substantial Gains'
Source: Clive Maund for Streetwise Reports  (11/21/19)
Technical analyst Clive Maund charts how news from this company affects its investment thesis. More >

Hepion Pharma Shares Climb 50% Higher on NASH Liver Disease Treatment Results
Source: Streetwise Reports  (11/21/19)
Shares of Hepion Pharmaceuticals opened higher today after the company reported that its anti-fibrotic agent CRV431 prevented the development of liver cirrhosis in a highly aggressive, preclinical liver disease model. More >

Zero-Commission Trading: Risks and Opportunities, Part 2
Source: Streetwise Reports  (11/20/19)
Part 2: Who Should Be Your Broker: Exploring which broker may be right for you. More >

Smart City Security Takes Shape in Mexico City with Lighting and Analytics Collaboration
Source: Streetwise Reports  (11/20/19)
The two firms are bringing together lighting, cameras and analytic technology. More >

ICAN Leverages Leading California Brand with Expansion into Nevada, Introduces State-of-the-Art Pre-Roll Machine, for Aggressive Near-Term Growth
Source: Knox Henderson for Streetwise Reports  (11/20/19)
A recent acquisition is helping this company to expand its brand. More >

Best Brokers for Research
Source: Streetwise Reports  (11/20/19)
Part 3 of Streetwise Reports' Online Brokerage series delves into the research brokerage firms offer. More >

Energy Firm to Divest Gas Infrastructure Assets for $500 Million
Source: Streetwise Reports  (11/20/19)
The Calgary-based oil & gas company states the transaction will add shareholder value and strengthen the balance sheet. More >

Explorer Receives $4M as First Payment from Sale of Asset in Turkey
Source: Streetwise Reports  (11/20/19)
With the funds, the Canadian company will fast track a drill program at its Idaho gold property. More >

Explorer to Drill Four Major Targets at North-Central Nevada Project
Source: Streetwise Reports  (11/20/19)
All four are Carlin-type gold targets. More >

Two Projects in Ecuador Mark 'Turning Point'
Source: Streetwise Reports  (11/20/19)
One project is in the exploration stage, while the other officially opens. More >

Explorer Drills 37.95 g/t Gold at BC Project
Source: Streetwise Reports  (11/20/19)
The company now intends to update the resource estimate. More >

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug
Source: Streetwise Reports  (11/20/19)
Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. More >

Junior Minor Cultivates Markets and Projects for Growth
Source: Maurice Jackson for Streetwise Reports  (11/20/19)
In conversation with Maurice Jackson of Proven and Probable, the CEO of this firm talks about prospects in Nevada and Canada's Yellowknife district, and discusses the company's financial strategy. More >

Explorer Hits More High Grades at Historical Gold-Silver Mine in Nevada
Source: Streetwise Reports  (11/20/19)
With preparatory work there now finished, that mine area is ready for drilling. More >

Zero-Commission Trading: Risks and Opportunities, Part 1
Source: Streetwise Reports  (11/19/19)
Part 1: What It All Means for Investors: Online brokers as investments. More >

Bob Moriarty: Mining Stocks that Have His Attention Right Now
Source: Maurice Jackson for Streetwise Reports  (11/19/19)
Bob Moriarty of 321gold, in conversation with Maurice Jackson of Proven and Probable, expounds on his views of geopolitics, and discusses metal prices as well as a number of mining companies that he finds attractive right now. More >

Myovant Sciences Shares Up 110% on Phase 3 Advanced Prostate Cancer Data
Source: Streetwise Reports  (11/19/19)
Shares of Myovant Sciences opened 120% higher today after the firm reported a 97% response rate in its Phase 3 HERO Study of oral Relugolix in men with advanced prostate cancer. In the study, Relugolix achieved all six key secondary endpoints and the firm expects to submit a New Drug Application in Q2/20. More >

Torchlight Firing on All Fronts in Texas
Source: Streetwise Reports  (11/18/19)
The company continues to prove up its holdings as it searches for a partner. More >

This Miner Could Offer Leverage to a Rising Gold Price
Source: Streetwise Reports  (11/18/19)
Over the past 20 years, this company's shares have outperformed gold by more than five to one. More >